Idecabtagene Vicleucel Infusion Suppliers & Bulk Manufacturers
Available Forms: IV Infusion
Available Strengths: Approved for relapsed/refractory multiple myeloma, with dosing based on patient weight, delivering a personalized, targeted therapy to eliminate cancer cells
Reference Brands: Abecma(US & EU)
Category: Cell & Gene Therapies
Idecabtagene vicleucel (Abecma) is a CAR T-cell therapy that reprograms a patient’s T cells to target BCMA, a protein on myeloma cells. It provides targeted, rapid cancer cell eradication, leading to durable responses, improved survival, and enhanced quality of life for relapsed/refractory multiple myeloma patients when administered in specialized centers.
Product Description:
Idecabtagene vicleucel (Abecma) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in line with GMP and MDR standards. FDA approval involved extensive clinical validation, safety assessment, and comparability data. In the EU, CE marking certifies conformity with MDR regulations. The product undergoes validation, stability testing, and audits, with comprehensive documentation including clinical trial results, safety profiles, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to innovative, life-saving CAR T-cell therapies for multiple myeloma and other hematologic malignancies globally, supporting improved patient outcomes and advanced cancer care.
Idecabtagene Vicleucel Infusion — third party manufacturing & bulk supply
Idecabtagene Vicleucel Infusion is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Idecabtagene Vicleucel Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Idecabtagene Vicleucel Infusion →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Darleukin Injection
Strength:
A standardized dose of 120 million adipose-derived stem cells per injection
Form: Intralesional injection
Reference Brands: Alofisel(US & EU)
View Details
Etranacogene Dezaparvovec. Infusion
Strength:
Single infusion product designed to produce sustained factor IX levels in hemophilia B patients, dosage individualized based on patient weight
Form: Intravenous infusion
Reference Brands: Hemgenix (US & EU)
View Details
Elivaldogene Autotemcel Infusion
Strength:
A personalized gene therapy designed to halt or slow ALD progression, dosed based on weight, administered as a single infusion in specialized treatment centers
Form: Intravenous infusion
Reference Brands: Skysona(US & EU)
View Details
Valoctocogene Roxaparvovec Infusion
Strength:
A single-dose gene therapy designed to increase factor VIII production in hemophilia A patients
Form: Intravenous infusion
Reference Brands: Roctavian(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
